- Home
- DNLI vs CVSA Comparison
DNLI vs CVSA Comparison
Compare DNLI & CVSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DNLI | CVSA |
|---|---|---|
| Founded | 2013 | 1987 |
| Country | United States | United States |
| Employees | N/A | 4996 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Other Consumer Services |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 4.3B |
| IPO Year | 2017 | N/A |
Fundamental Metrics
Financial Performance| Metric | DNLI | CVSA |
|---|---|---|
| Price | $23.02 | $124.85 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 14 | 2 |
| Target Price | $34.33 | ★ $150.00 |
| AVG Volume (30 Days) | ★ 1.7M | 328.7K |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $9.66 |
| Revenue Next Year | $408.85 | $6.58 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $12.58 | $96.08 |
| 52 Week High | $27.30 | $135.96 |
Technical Indicators
Market Signals| Indicator | DNLI | CVSA |
|---|---|---|
| Relative Strength Index (RSI) | 46.93 | 51.60 |
| Support Level | $18.27 | $115.79 |
| Resistance Level | $27.30 | $133.44 |
| Average True Range (ATR) | 1.20 | 6.23 |
| MACD | -0.15 | 0.82 |
| Stochastic Oscillator | 29.20 | 59.50 |
Price Performance
Historical ComparisonAbout DNLI Denali Therapeutics Inc.
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegenerative diseases. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others. The Company has one operating segment with the goal to discover, develop, and commercializing therapeutics.
About CVSA Covista Inc. Common Shares
Covista Inc is an American healthcare educator, serving more than 97,000 students and supported by a community of alumni across five accredited institutions. Through personalized, tech-enabled education powered by faculty and colleagues, it expands access to healthcare careers and addresses the U.S. healthcare workforce shortage at scale.